We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$177M
AUM Growth
+$18.7M
Cap. Flow
+$5.4M
Cap. Flow %
3.04%
Top 10 Hldgs %
18.89%
Holding
982
New
339
Increased
167
Reduced
226
Closed
62

Top Buys

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$1.5M
2
ARE icon
Alexandria Real Estate Equities
ARE
+$1.48M
3
SON icon
Sonoco
SON
+$1.42M
4
R icon
Ryder
R
+$1.39M
5
AMT icon
American Tower
AMT
+$1.38M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$1.78M
2
IBM icon
IBM
IBM
+$1.56M
3
INGR icon
Ingredion
INGR
+$1.48M
4
ELV icon
Elevance Health
ELV
+$1.47M
5
MDT icon
Medtronic
MDT
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 20.99%
2 Real Estate 18.63%
3 Industrials 12.95%
4 Healthcare 10.2%
5 Consumer Staples 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LITE icon
826
Lumentum
LITE
$63.3B
$991 ﹤0.01%
+19
New +$1.17K
JEPI icon
827
JPMorgan Equity Premium Income ETF
JEPI
$46B
$983 ﹤0.01%
+18
New +$978
NEM icon
828
Newmont
NEM
$124B
$980 ﹤0.01%
+21
New +$938
PETQ
829
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$977 ﹤0.01%
106
PSEC icon
830
Prospect Capital
PSEC
$1.15B
$955 ﹤0.01%
+137
New +$985
GDRX icon
831
GoodRx Holdings
GDRX
$1.25B
$904 ﹤0.01%
194
-888
-82% -$4.38K
NEWR
832
DELISTED
New Relic, Inc.
NEWR
$903 ﹤0.01%
+16
New +$905
TSQ icon
833
Townsquare Media
TSQ
$108M
$892 ﹤0.01%
+123
New +$927
JBHT icon
834
JB Hunt Transport Services
JBHT
$25B
$872 ﹤0.01%
+5
New +$873
LOAN
835
Manhattan Bridge Capital
LOAN
$47.6M
$872 ﹤0.01%
+164
New +$910
EDIT icon
836
Editas Medicine
EDIT
$432M
$869 ﹤0.01%
98
MDC
837
DELISTED
M.D.C. Holdings, Inc.
MDC
$869 ﹤0.01%
28
+1
+4% +$31
BLUE
838
DELISTED
bluebird bio
BLUE
$865 ﹤0.01%
6
-1
-14% -$141
AUPH icon
839
Aurinia Pharmaceuticals
AUPH
$2.06B
$864 ﹤0.01%
200
NKLA
840
DELISTED
Nikola Corporation Common Stock
NKLA
$864 ﹤0.01%
+13
New +$1.09K
TSHA icon
841
Taysha Gene Therapies
TSHA
$1.83B
$859 ﹤0.01%
380
JPIE icon
842
JPMorgan Income ETF
JPIE
$10.3B
$857 ﹤0.01%
+19
New +$851
JEMA icon
843
JPMorgan ActiveBuilders Emerging Markets Equity ETF
JEMA
$1.65B
$838 ﹤0.01%
+25
New +$838
NORW icon
844
Global X MSCI Norway ETF
NORW
$87M
$821 ﹤0.01%
+32
New +$799
WAB icon
845
Wabtec
WAB
$49.7B
$802 ﹤0.01%
8
-3
-27% -$287
AOUT icon
846
American Outdoor Brands
AOUT
$160M
$772 ﹤0.01%
77
QMCO icon
847
Quantum Corp
QMCO
$464M
$749 ﹤0.01%
34
EFNL icon
848
iShares MSCI Finland ETF
EFNL
$247M
$748 ﹤0.01%
+20
New +$708
SLB icon
849
SLB Ltd
SLB
$78.9B
$748 ﹤0.01%
14
U icon
850
Unity
U
$19B
$715 ﹤0.01%
+25
New +$783

Similar funds

Truvestments Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Truvestments Capital held 982 positions worth $177M, up 12% from $159M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Truvestments Capital deployed $5.4M of net new capital in Q4 2022, opening 339 new positions and adding to 167 existing holdings. Its largest new stake was Coterra Energy: 54,452 shares worth $1.34M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Real Estate and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $1.78M trimmed.

  • Truvestments Capital's largest Q4 2022 buy was Coterra Energy: 54,452 shares worth $1.34M.
  • Truvestments Capital added most to Alexandria Real Estate Equities in Q4 2022, an estimated $1.48M increase.
  • Truvestments Capital's biggest Q4 2022 reduction was AbbVie, cutting an estimated $1.78M.
  • Truvestments Capital fully exited Twitter, Inc. in Q4 2022, selling an estimated $374K.
  • Truvestments Capital's ten largest holdings make up 19% of its $177M portfolio in Q4 2022.
  • Truvestments Capital opened 339 new positions and closed 62 in Q4 2022.
  • Truvestments Capital's portfolio value rose 12% quarter-over-quarter to $177M.

Based on Truvestments Capital's 13F filing for Q4 2022, filed 14 Feb 2023.